Accueil Livres eBooks Revues spécialisées Références et comptes rendus Auteurs, éditeurs, examinateurs Index A-Z des produits Récompenses
Critical Reviews™ in Oncogenesis
SJR: 0.631 SNIP: 0.503 CiteScore™: 2.2

ISSN Imprimer: 0893-9675
ISSN En ligne: 2162-6448

Critical Reviews™ in Oncogenesis

Editor-in-Chief: Benjamin Bonavida

Associate Editor: Vipin Kumar

Volume 25, Issues 1 and 2, 2020 are currently in production for early summer publication.

Objectifs et champs d'application

The primary objective of the Critical Reviews in Oncogenesis (CRO) is the update and dissemination of scientific and clinical knowledge pertaining to the underlying molecular bases of oncogenesis by emphasizing both the journal's originality and scientific merit. CRO is dedicated to publishing timely critical reviews on topics of current interests with emphases on basic, molecular and translational applications in the field of oncogenesis. Further emphasis is focused on the roles of oncogenesis in the development of cancer and malignancies and cancer stem cells and their oncogenic potential. Reviews also consider the role of oncogenes as diagnostic biomarkers and therapeutic targets. Hence, CRO publishes special thematic issues on the above described topics and emphasizes multidisciplinary approaches.
In contrast to reviews in several other publications, CRO is highly focused on a specific and a unique thematic approach for each issue, edited by invited Editor(s), with contributions by various experts. This multidisciplinary approach for a coherent theme in Oncogenesis distinguishes CRO from many other review journal in which individual reviews that are not always interrelated, are often published. The unique Aims and Scope of CRO will lead to a wide readership and will be used as an essential reference for research scientists, clinicians, students, health professionals, and biopharmaceutical industries.

La plupart des articles téléchargés

Immunotherapy for EBV-Associated Nasopharyngeal Carcinoma
Mengying Hong, Kejun Tang, Jing Qian, Hongyu Deng, Musheng Zeng, Shu Zheng, Kefeng Ding, Yushen Du, Ren Sun

Gemcitabine: A Review of Chemoresistance in Pancreatic Cancer
Deepika Sarvepalli, Mamoon Ur Rashid, Asad Ur Rahman, Waqas Ullah, Ishtiaq Hussain, Badar Hasan, Sundas Jehanzeb, Abdul Kareem Khan, Akriti Gupta Jain, Neelam Khetpal, Sarfraz Ahmad

Current Perspectives of Exosomes as Therapeutic Targets and Drug Delivery Vehicles for Pancreatic Cancer
L. Srinivas, Deepthi S, Deepak KGK, Rama Rao Malla

Newer Trends in Pancreatic Cancer Treatment: Genetic Alterations and the Role of Immune Therapeutic and Targeted Therapies
Ishtiaq Hussain, Mamoon Ur Rashid, Deepika Sarvepalli, Asad ur Rahman, Waqas Ullah, Hasan Badar, Sundas Jehanzeb, Abdul Kareem Khan, Muhammad Talha Khan, Muhammad Muzammil, Sarfraz Ahmad

Gaucher Disease: A Comprehensive Review
Barry E. Rosenbloom, Neal J. Weinreb

Pancreatic Cancer: An Emphasis on Current Perspectives in Immunotherapy
Krishna Patel, Sohail Siraj, Chloe Smith, Maya Nair, Jamboor K. Vishwanatha, Riyaz Basha